-
Two recent studies have found that concomitant use of prescription medications and dietary supplements is common.
-
Osteopathic manipulative therapy (OMT) during the third trimester appears to help prevent the progression of back pain and the loss of back functioning with time.
-
A recent study has shown a link between abnormal uterine artery waveforms in the second trimester and reduced fetal movements later in pregnancy, as well as with stillbirth and small for gestational age.
-
Olaparib, a poly (ADP)-ribose polymerase (PARP) inhibitor, demonstrated substantial delay until progression when administered to women as a maintenance therapy with BRCA-mutant recurrent ovarian cancer.
-
Serum anti-Mullerian hormone (AMH) has been well-established as an accurate marker of ovarian reserve. It is solely produced in the human ovary by the granulosa cells.
-
A review of the published literature finds no value to the routine screening pelvic examination in asymptomatic non-pregnant women.
-
A second inhalation rapid human insulin has been approved by the FDA. The first inhaled insulin (Exubera) was approved in 2006 and was withdrawn from the market by Pfizer due to low acceptance and poor sales after about 13 months on the market
-
In a meta-analysis of multiple prospective cohort studies, the lowest vitamin D metabolite (25-hydroxyvitamin D) quintile was associated with increased all-cause mortality, cardiovascular mortality, and cancer mortality.
-
-
Contrary to prevailing opinion, eating lean beef may not be bad and perhaps might even favorably affect systolic blood pressure and vascular constriction.